Leadership Overview
Johnson & Johnson Services Inc has 10 executives leading key functions including strategy, supply chain, information technology, finance, procurement, medical affairs, business development, and operations.
Driven by a commitment to innovation, Johnson & Johnson Services Inc develops pharmaceuticals and medical technologies, providing essential medicines and devices to healthcare providers and patients globally across critical areas like oncology and cardiovascular care.
Driven by a commitment to innovation, Johnson & Johnson Services Inc develops pharmaceuticals and medical technologies, providing essential medicines and devices to healthcare providers and patients globally across critical areas like oncology and cardiovascular care.
Leadership Roles at Johnson & Johnson Services Inc
Joaquin Duato - Chief Executive Officer
Joaquin Duato, the Chief Executive Officer at Johnson & Johnson Services Inc, directs the company's overarching strategy and global operations. This leadership role involves guiding the development and delivery of innovative medicines, surgical products, and medical devices across critical therapeutic areas such as oncology, immunology, neuroscience, and cardiovascular care. Duato ensures alignment with the company's mission to advance health for humanity. Overseeing all business segments, the Chief Executive Officer drives market expansion and fosters a culture of scientific excellence and patient-centricity. Joaquin Duato's strategic vision shapes the company's response to evolving healthcare needs worldwide, solidifying its position as a global leader in pharmaceuticals and medical technologies. The executive's focus remains on sustainable growth and enhancing patient outcomes through cutting-edge solutions.

Lauren Johnson - Chief Financial Officer, External Innovation Finance
Lauren Johnson, the Chief Financial Officer, External Innovation Finance at Johnson & Johnson Services Inc, directs financial strategy for the company's external innovation initiatives. This critical role involves evaluating and managing financial investments in new technologies and partnerships that align with Johnson & Johnson's pharmaceutical and medical device development goals. Johnson oversees financial planning, analysis, and reporting for external innovation ventures, ensuring fiscal responsibility and maximizing return on investment. The Chief Financial Officer, External Innovation Finance plays a key part in identifying and securing funding for promising external opportunities that can accelerate the development of innovative medicines and medical technologies. Lauren Johnson's financial acumen supports the company's commitment to advancing healthcare solutions through strategic external collaborations and investments.
Daniel Foo - Director, Finance (Surgery) & Chief Financial Officer, Medtech Anz
Daniel Foo, the Director, Finance (Surgery) & Chief Financial Officer, Medtech Anz at Johnson & Johnson Services Inc, leads financial operations for the Surgery segment within the Australia and New Zealand region. This dual role encompasses strategic financial planning, budgeting, and analysis to support the growth and profitability of the MedTech business in ANZ. Foo ensures financial compliance and optimizes resource allocation for surgical product lines. The Chief Financial Officer, Medtech Anz provides critical financial insights to regional leadership, driving performance and supporting market expansion initiatives. Daniel Foo's financial stewardship is essential for navigating the complex healthcare market in ANZ and ensuring the successful delivery of innovative surgical technologies. This executive's focus is on driving financial excellence within a key geographic market.
Christian Cuzick - Worldwide President, Neurovascular
Christian Cuzick, the Worldwide President, Neurovascular at Johnson & Johnson Services Inc, directs the global strategy and operations for the Neurovascular business unit. This leadership position involves overseeing the development, marketing, and sales of advanced medical technologies and devices used in the treatment of neurological conditions. Cuzick drives innovation within the neurovascular field, ensuring the delivery of cutting-edge solutions to healthcare providers and patients worldwide. The Worldwide President, Neurovascular fosters cross-functional collaboration to enhance product pipelines and expand market reach. Christian Cuzick's strategic oversight is essential for advancing patient care in neurovascular interventions and solidifying Johnson & Johnson's leadership in this critical medical specialty.
Maitali Hans - Supply Chain Procurement Director, Project Management Office & Chief of Staff
Maitali Hans, the Supply Chain Procurement Director, Project Management Office & Chief of Staff at Johnson & Johnson Services Inc, manages critical procurement functions and drives strategic project execution. This role involves optimizing the supply chain for pharmaceuticals and medical technologies, ensuring efficient sourcing and delivery of essential materials. Hans also leads the Project Management Office, overseeing key initiatives that enhance operational efficiency and support the company's growth objectives. As Chief of Staff, Maitali Hans provides strategic support to executive leadership, facilitating cross-functional collaboration and driving key organizational priorities. The executive's responsibilities extend to ensuring seamless integration of project management methodologies across departments, directly impacting the timely delivery of innovative healthcare solutions. Maitali Hans's leadership ensures robust supply chain resilience and effective project governance.
Jeff Srour - Worldwide Vice President & Chief Information Officer, MedTech
Jeff Srour, the Worldwide Vice President & Chief Information Officer, MedTech at Johnson & Johnson Services Inc, architects the technology strategy for the MedTech division. This leadership position involves overseeing the development and implementation of digital solutions that support the innovation, manufacturing, and distribution of surgical products and medical devices. Srour drives digital transformation initiatives, enhancing operational efficiency and enabling data-driven decision-making across global MedTech operations. The Chief Information Officer ensures robust cybersecurity measures and scalable IT infrastructure to support the division's expanding portfolio. Jeff Srour's expertise in information technology is crucial for advancing the MedTech business, fostering innovation, and improving healthcare delivery through advanced technological platforms. This role directly impacts the company's ability to provide cutting-edge medical technologies worldwide.

Nina Martinez - Category Director, Innovative Medicine Procurement, Functional Chief Revenue Officer and Clinical Services
Nina Martinez, the Category Director, Innovative Medicine Procurement, Functional Chief Revenue Officer and Clinical Services at Johnson & Johnson Services Inc, oversees strategic procurement for innovative medicines and drives revenue generation through clinical services. This multifaceted role involves managing the acquisition of critical pharmaceutical components and developing strategies to enhance revenue streams from clinical offerings. Martinez ensures the efficient procurement of high-value medicines while also optimizing the delivery and financial performance of clinical services. The Functional Chief Revenue Officer and Clinical Services Director collaborates across departments to align procurement and revenue strategies, supporting the company's mission to provide essential healthcare solutions. Nina Martinez's leadership integrates procurement excellence with robust revenue generation, contributing significantly to the company's market presence and financial health.
Danielle Gomes - Chief Information Officer, J & J Medtech LATAM
Danielle Gomes, the Chief Information Officer, J & J Medtech LATAM at Johnson & Johnson Services Inc, directs the information technology strategy for the MedTech division across Latin America. This leadership role involves implementing and managing robust IT infrastructure and digital solutions to support the region's surgical products and medical device operations. Gomes drives technological innovation, enhancing operational efficiency and enabling data-driven insights for the LATAM MedTech business. The Chief Information Officer ensures cybersecurity resilience and scalable IT systems to meet the evolving demands of the healthcare market in Latin America. Danielle Gomes's expertise is vital for advancing the MedTech division's technological capabilities, fostering growth, and improving healthcare access through innovative medical technologies in the region.

Hideharu Shimizu - Chief Medical Officer(Tokyo)
Hideharu Shimizu, the Chief Medical Officer(Tokyo) at Johnson & Johnson Services Inc, provides critical medical leadership and strategic guidance for operations based in Tokyo. This role involves overseeing medical affairs, ensuring adherence to the highest standards of patient care and safety in the development and application of pharmaceuticals and medical technologies. Shimizu contributes medical expertise to research and development initiatives, particularly those focused on the Japanese market. The Chief Medical Officer(Tokyo) collaborates with regulatory bodies and healthcare professionals to advance medical understanding and adoption of J&J's innovative solutions. Hideharu Shimizu's medical insights are instrumental in shaping the company's approach to healthcare challenges and opportunities within Japan, reinforcing its commitment to improving patient outcomes.
David He - Vice President, Business Development (Asia Pacific)
David He, the Vice President, Business Development (Asia Pacific) at Johnson & Johnson Services Inc, spearheads strategic growth initiatives and partnership development across the Asia Pacific region. This executive role focuses on identifying and securing new business opportunities that align with the company's pharmaceutical and medical technology objectives. He leads market analysis and evaluates potential collaborations to expand Johnson & Johnson's presence and product offerings in key APAC markets. The Vice President, Business Development drives the negotiation and execution of strategic alliances, mergers, and acquisitions. David He's leadership in business development is crucial for fostering innovation and ensuring sustained growth for Johnson & Johnson throughout the dynamic Asia Pacific healthcare landscape.
Explore Leadership Teams in Manufacturing
Established in 2009, Apellis is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds for the treatment of a broad range of life-threatening or debilitating autoimmune diseases based upon complement immunotherapy through the inhibition of the complement system at the level of C3. They are based in Waltham, Massachusetts.
Company Leadership TS

KM
Founded in 1971 and headquartered in Hauppauge, New York, Contract Pharmacal (CPC) is a company that manufactures and packages pharmaceuticals, over-the-counter drugs, and dietary supplements for pharmaceutical companies, retailers, and wholesalers worldwide.
Company Leadership

MW
Shionogi & Co., Ltd. is a Japanese pharmaceutical company dedicated to developing innovative treatments that improve patient lives worldwide. With a longstanding focus on addressing pressing global health challenges, the company has been a pioneer in discovering and delivering novel therapies for infectious diseases, including antibiotics, HIV, influenza, and emerging viral threats such as COVID-19. Shionogi combines in-house research and development with strategic collaborations across industry, government agencies, biotech companies, and academic institutions to accelerate the advancement of its scientific programs and bring meaningful therapies to patients with urgency and precision.
Company Leadership
TK
MF
TN
Vanda Pharmaceuticals, founded in 2003, is a biopharmaceutical research and development company focused on creating innovative medicines to improve patient lives. The company leverages advanced technologies including genetics and genomics to guide drug discovery, clinical trials, and commercial strategies. Vanda Pharmaceuticals specializes in developing novel therapeutic approaches and delivery methods for their pharmaceutical products. With operations across North America, Europe, and Asia, the company maintains a global presence in the pharmaceutical industry while continuing to advance medical research and drug development for various health conditions.
Company Leadership BA

PJ
JW